Pacific Biosciences Of California (PACB)
Pacific Biosciences Of California on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as laboratory analytical instruments.
47.2M
Short interest
settlement 2026-09-30
3.0
Days to cover
-7.5 days vs prior
40.5%
Short share of volume
2026-10-09
4,275
Fails to deliver
settlement 2026-09-08
Wed 4 Nov
Next earnings
estimated date
-$2.1M
Insider flow, 90 days
0 buys, 2 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in PACB is 47,224,448 shares, down 2,354,322 shares over the last month. Over the last 48 readings it ranged from 32,511,384 shares (31 October 2025) to 66,690,554 shares (14 February 2025). At the reported average volume of 15.9M shares a day that is 3.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/pacb" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 47,224,448 | -3.4% | 15,907,977 | 2.97 |
| 2026-09-15 | 48,892,225 | -1.4% | 4,660,230 | 10.49 |
| 2026-08-31 | 49,578,770 | -7.2% | 7,342,641 | 6.75 |
| 2026-08-14 | 53,412,027 | +9.0% | 8,056,891 | 6.63 |
| 2026-07-31 | 49,004,841 | +6.0% | 6,666,706 | 7.35 |
| 2026-07-15 | 46,237,636 | -2.6% | 4,638,329 | 9.97 |
| 2026-06-30 | 47,490,204 | -21.6% | 7,291,153 | 6.51 |
| 2026-06-15 | 60,560,138 | +24.3% | 5,954,109 | 10.17 |
| 2026-05-29 | 48,707,384 | -18.7% | 5,684,330 | 8.57 |
| 2026-05-15 | 59,926,798 | +27.3% | 6,645,578 | 9.02 |
| 2026-04-30 | 47,090,593 | +1.6% | 6,688,960 | 7.04 |
| 2026-04-15 | 46,364,406 | +1.6% | 5,505,784 | 8.42 |
| 2026-03-31 | 45,631,632 | +10.3% | 5,428,096 | 8.41 |
| 2026-03-13 | 41,388,621 | +8.4% | 6,304,987 | 6.56 |
| 2026-02-27 | 38,191,242 | -1.9% | 5,352,300 | 7.14 |
| 2026-02-13 | 38,916,811 | +9.3% | 7,386,819 | 5.27 |
| 2026-01-30 | 35,591,593 | +1.4% | 8,377,033 | 4.25 |
| 2026-01-15 | 35,091,747 | +3.2% | 8,781,846 | 4.00 |
| 2025-12-31 | 34,003,835 | -0.8% | 6,403,082 | 5.31 |
| 2025-12-15 | 34,259,532 | +0.6% | 6,286,336 | 5.45 |
| 2025-11-28 | 34,042,917 | +1.4% | 11,064,220 | 3.08 |
| 2025-11-14 | 33,569,699 | +3.3% | 9,267,258 | 3.62 |
| 2025-10-31 | 32,511,384 | -5.8% | 11,362,122 | 2.86 |
| 2025-10-15 | 34,508,178 | -9.1% | 8,397,808 | 4.11 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of PACB volume is 40.5%, down 2.2 points over the last five sessions. Over the last 30 readings it ranged from 25.6% (28 September 2026) to 54.9% (23 September 2026). The latest reading is 2.4 points below the 30-session average of 42.9%, on 5.5M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 2.2M | 5.5M | 40.5% | 239,946 |
| 2026-10-08 | 3.3M | 9.5M | 34.8% | 288,031 |
| 2026-10-07 | 4.4M | 8.8M | 49.9% | 326,520 |
| 2026-10-06 | 12.3M | 24.0M | 51.1% | 590,872 |
| 2026-10-05 | 4.4M | 12.6M | 35.1% | 608 |
| 2026-10-02 | 5.0M | 11.7M | 42.8% | 22,668 |
| 2026-10-01 | 5.9M | 12.5M | 47.5% | 16,111 |
| 2026-09-30 | 14.8M | 38.2M | 38.8% | 65,082 |
| 2026-09-29 | 2.5M | 7.3M | 34.2% | 6,580 |
| 2026-09-28 | 2.3M | 9.0M | 25.6% | 23,896 |
| 2026-09-25 | 1.5M | 4.1M | 37.3% | 75,961 |
| 2026-09-24 | 1.9M | 4.6M | 39.9% | 1,070 |
| 2026-09-23 | 1.3M | 2.3M | 54.9% | 635 |
| 2026-09-22 | 1.1M | 3.7M | 29.6% | 3,642 |
| 2026-09-21 | 1.0M | 2.7M | 38.4% | 37,952 |
| 2026-09-18 | 699K | 1.6M | 45.1% | 870 |
| 2026-09-17 | 1.7M | 3.2M | 53.7% | 115,102 |
| 2026-09-16 | 860K | 1.9M | 45.1% | 15,086 |
| 2026-09-15 | 1.3M | 2.7M | 45.8% | 28,103 |
| 2026-09-14 | 934K | 2.4M | 38.7% | 253 |
| 2026-09-11 | 619K | 1.6M | 37.8% | 58 |
| 2026-09-10 | 1.4M | 2.6M | 54.0% | 4,902 |
| 2026-09-09 | 942K | 2.0M | 46.3% | 0 |
| 2026-09-08 | 866K | 1.9M | 45.0% | 5,226 |
| 2026-09-04 | 587K | 1.2M | 50.1% | 4,966 |
| 2026-09-03 | 1.3M | 2.8M | 45.4% | 4,374 |
| 2026-09-02 | 1.0M | 2.2M | 48.4% | 0 |
| 2026-09-01 | 1.8M | 3.8M | 46.9% | 83,401 |
| 2026-08-31 | 1.6M | 3.8M | 42.3% | 90,771 |
| 2026-08-28 | 1.2M | 2.8M | 41.7% | 24,444 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 8 September 2026, the fails-to-deliver balance in PACB is 4,275 shares, up 4,195 shares over the last settlement date. Over the last 30 readings it ranged from 70 shares (7 August 2026) to 906,304 shares (6 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-08 | 4,275 | $1.35 | $6K |
| 2026-08-27 | 80 | $1.56 | $125 |
| 2026-08-26 | 56,521 | $1.52 | $86K |
| 2026-08-25 | 2,314 | $1.28 | $3K |
| 2026-08-24 | 16,495 | $1.35 | $22K |
| 2026-08-20 | 7,038 | $1.27 | $9K |
| 2026-08-18 | 55,011 | $1.21 | $67K |
| 2026-08-17 | 8,674 | $1.15 | $10K |
| 2026-08-13 | 152,647 | $1.11 | $169K |
| 2026-08-07 | 70 | $1.17 | $82 |
| 2026-08-06 | 906,304 | $1.30 | $1.2M |
| 2026-07-31 | 531 | $1.48 | $786 |
| 2026-07-30 | 1,270 | $1.40 | $2K |
| 2026-07-23 | 56,994 | $1.38 | $79K |
| 2026-07-20 | 141,083 | $1.44 | $203K |
| 2026-07-13 | 7,744 | $1.56 | $12K |
| 2026-07-07 | 103 | $1.66 | $171 |
| 2026-07-06 | 78,369 | $1.68 | $132K |
| 2026-07-02 | 43,723 | $1.74 | $76K |
| 2026-06-30 | 493,358 | $1.73 | $854K |
| 2026-06-29 | 286,839 | $1.65 | $473K |
| 2026-06-17 | 7,125 | $1.35 | $10K |
| 2026-06-15 | 601,723 | $1.31 | $788K |
| 2026-06-11 | 25,663 | $1.37 | $35K |
| 2026-06-10 | 10,648 | $1.37 | $15K |
| 2026-06-08 | 42,373 | $1.45 | $61K |
| 2026-06-05 | 655 | $1.63 | $1K |
| 2026-06-04 | 44,380 | $1.58 | $70K |
| 2026-06-03 | 138,780 | $1.58 | $219K |
| 2026-05-29 | 157,785 | $1.47 | $232K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at PACB reported 2 open-market sells worth $2.1M in the last 90 days and no open-market buys. Latest filing: Gibson James R II (See Remarks) on 2026-10-06.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Gibson James R II | See Remarks | Sell | 662K | $3.11 | $2.1M | 1.1M |
| 2026-10-06 | Gibson James R II | See Remarks | Option exercise | 500K | $1.18 | $590K | 1.7M |
| 2026-08-17 | Van Oene Mark | See Remarks | Sell | 27K | $1.13 | $30K | 2.7M |
| 2026-08-10 | Van Oene Mark | See Remarks | Grant | 489K | $0.00 | $0 | 2.7M |
| 2026-04-08 | Gibson Christopher | Director | Grant | 57K | $0.00 | $0 | 111K |
| 2026-04-01 | Gibson James R II | See Remarks | Sell | 88K | $1.37 | $121K | 1.2M |
| 2026-03-03 | Van Oene Mark | See Remarks | Sell | 7K | $1.51 | $10K | 2.2M |
| 2026-03-03 | HENRY CHRISTIAN O | See Remarks | Sell | 12K | $1.51 | $19K | 3.6M |
| 2026-03-03 | Farmer Michele | See Remarks | Sell | 3K | $1.51 | $5K | 306K |
| 2026-03-03 | Gibson Christopher | Director | Grant | 54K | $0.00 | $0 | 54K |
| 2026-02-27 | Van Oene Mark | See Remarks | Grant | 500K | $0.00 | $0 | 2.2M |
| 2026-02-27 | HENRY CHRISTIAN O | See Remarks | Grant | 921K | $0.00 | $0 | 3.6M |
| 2026-02-27 | Gibson James R II | See Remarks | Grant | 334K | $0.00 | $0 | 1.3M |
| 2026-02-27 | Farmer Michele | See Remarks | Grant | 90K | $0.00 | $0 | 309K |
| 2026-02-18 | Van Oene Mark | See Remarks | Sell | 55K | $1.63 | $90K | 1.7M |
| 2026-02-18 | HENRY CHRISTIAN O | See Remarks | Sell | 141K | $1.63 | $229K | 2.7M |
| 2026-02-18 | Farmer Michele | See Remarks | Sell | 15K | $1.63 | $24K | 219K |
| 2026-02-17 | Van Oene Mark | See Remarks | Sell | 130K | $1.58 | $205K | 1.8M |
| 2026-02-17 | HENRY CHRISTIAN O | See Remarks | Sell | 332K | $1.58 | $523K | 2.8M |
| 2026-02-17 | Farmer Michele | See Remarks | Sell | 35K | $1.58 | $55K | 234K |
| 2025-08-18 | Van Oene Mark | See Remarks | Sell | 27K | $1.31 | $35K | 1.9M |
| 2025-05-19 | Farmer Michele | See Remarks | Sell | 5K | $1.00 | $5K | 269K |
| 2025-03-31 | Gibson James R II | See Remarks | Grant | 1.0M | $0.00 | $0 | 1.0M |
| 2025-03-19 | HENRY CHRISTIAN O | See Remarks | Grant | 921K | $0.00 | $0 | 3.1M |
| 2025-03-19 | Van Oene Mark | See Remarks | Grant | 449K | $0.00 | $0 | 1.9M |
| 2025-03-19 | Farmer Michele | See Remarks | Grant | 90K | $0.00 | $0 | 274K |
| 2025-03-03 | Farmer Michele | See Remarks | Sell | 3K | $1.41 | $4K | 185K |
| 2025-03-03 | Van Oene Mark | See Remarks | Sell | 6K | $1.41 | $9K | 1.5M |
| 2025-03-03 | HENRY CHRISTIAN O | See Remarks | Sell | 12K | $1.41 | $18K | 2.2M |
| 2025-02-18 | HENRY CHRISTIAN O | See Remarks | Sell | 260K | $1.88 | $489K | 2.2M |
| 2025-02-18 | Van Oene Mark | See Remarks | Sell | 101K | $1.88 | $189K | 1.5M |
| 2025-02-18 | Farmer Michele | See Remarks | Sell | 24K | $1.88 | $46K | 188K |
| 2025-01-30 | Smith Christopher M | Director | Grant | 54K | $0.00 | $0 | 54K |
| 2025-01-10 | Van Oene Mark | See Remarks | Sell | 34K | $2.03 | $70K | 1.6M |
| 2024-09-30 | Kim Susan G. | See Remarks | Sell | 20K | $1.72 | $34K | 696K |
| 2024-09-16 | HENRY CHRISTIAN O | See Remarks | Sell | 99K | $1.75 | $173K | 2.5M |
| 2024-08-19 | Eidel Jeff | See Remarks | Sell | 27K | $1.59 | $43K | 870K |
| 2024-08-16 | Van Oene Mark | See Remarks | Sell | 38K | $1.66 | $63K | 1.6M |
| 2024-06-18 | Ericson William W. | Director | Grant | 23K | $0.00 | $0 | 42K |
| 2024-06-18 | LIVINGSTON RANDALL S | Director | Grant | 23K | $0.00 | $0 | 23K |
| 2024-06-18 | Meline David W | Director | Grant | 17K | $0.00 | $0 | 57K |
| 2024-06-18 | MILLIGAN JOHN F | Director | Grant | 23K | $0.00 | $0 | 133K |
| 2024-06-18 | MOHR MARSHALL | Director | Grant | 23K | $0.00 | $0 | 133K |
| 2024-06-18 | ORDONEZ KATHY | Director | Grant | 23K | $0.00 | $0 | 403K |
| 2024-06-18 | Shapiro Lucy | Director | Grant | 23K | $0.00 | $0 | 23K |
| 2024-06-18 | Valantine Hannah | Director | Grant | 23K | $0.00 | $0 | 23K |
| 2024-05-20 | Farmer Michele | See Remarks | Sell | 5K | $2.03 | $11K | 212K |
| 2024-03-15 | ORDONEZ KATHY | Director | Option exercise | 325K | $2.90 | $941K | 343K |
| 2024-03-15 | ORDONEZ KATHY | Director | Option exercise | 37K | $2.63 | $98K | 380K |
| 2024-03-06 | Meline David W | Director | Buy | 40K | $4.40 | $176K | 40K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON7 Form 144 notices on file for PACB worth $3.5M at the prices reported; 2 in the last 90 days worth $1.9M. Latest: Jim Gibson filed on 2026-10-06 to sell 661,815 shares ($1.9M) from 2026-10-06.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-06 | Jim GibsonOfficer | 662K | $1.9M | 0.213% | 2026-10-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | MARK VAN OENEOfficer | 27K | $31K | 0.009% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-01 | JAMES GIBSONOfficer | 88K | $121K | 0.029% | 2026-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-03 | MARK D. VAN OENEOfficer | 7K | $10K | 0.002% | 2026-03-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-03 | CHRISTIAN HENRYOfficer | 12K | $19K | 0.004% | 2026-03-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | MARK VAN OENEOfficer | 304K | $479K | 0.101% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | CHRISTIAN HENRYOfficer | 606K | $956K | 0.201% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of PACB in their latest filing, all on Schedule 13G (passive). The largest reported stake is ARK Investment Management LLC at 9.6% of the class (29,781,416 shares), filed 2026-08-14 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 7 | ARK Investment Management LLCinvestment adviser | 29.8M | 9.6% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 7 | Catherine D. Woodparent holding company, individual | 29.8M | 9.6% | 2026-06-30 |
| 2026-03-27 | 13G/Ano. 4 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-11-14 | 13G/Ano. 5 | Gregory Boyd Pennerindividual | 8.5M | 2.8% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Madrone Opportunity Fund, L.P.partnership | 5.0M | 1.7% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Madrone Capital Partners, LLCother entity | 5.0M | 1.7% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Jameson J. McJunkinindividual | 5.0M | 1.7% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Thomas Pattersonindividual | 5.0M | 1.7% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Shimoda Holdings, LLCother entity | 3.5M | 1.2% | 2025-09-30 |
13F holders
Tracked managers holding PACB at their latest 13F. JSON9 of the 30 tracked managers held PACB at their latest 13F, $87.7M in total at quarter-end prices. ARK Investment Management is the largest at $50.0M (0.3% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| ARK Investment Management | 2026-06-30 | 29.8M | $50.0M | 0.32% | -6.5M |
| Point72 Asset Management | 2026-06-30 | 4.8M | $8.0M | 0.01% | +4.5M |
| Two Sigma Investments | 2026-06-30 | 4.2M | $7.1M | 0.01% | +733K |
| D. E. Shaw & Co. | 2026-06-30 | 4.2M | $7.1M | 0.00% | +571K |
| Millennium Management | 2026-06-30 | 4.0M | $6.7M | 0.00% | -930K |
| Citadel Advisors | 2026-06-30 | 2.8M | $4.8M | 0.00% | +1.3M |
| AQR Capital Management | 2026-06-30 | 1.3M | $2.2M | 0.00% | +537K |
| Renaissance Technologies | 2026-06-30 | 966K | $1.6M | 0.00% | -1.5M |
| Bridgewater Associates | 2026-06-30 | 103K | $173K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Pacific Biosciences Of California in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Pacific Biosciences Of California (PACB), SEC CIK 1299130, listed on Nasdaq, classified by the SEC as laboratory analytical instruments. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-08.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-06.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-06.JSON and CSV
- Company record
- EDGAR filing index for CIK 1299130Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as laboratory analytical instruments
Other company pages
Datasets
Frequently Asked Questions
How much of PACB is sold short?
What is PACB's daily short volume?
Does PACB have fails to deliver?
Are PACB insiders buying or selling?
Have PACB insiders filed to sell?
Who owns 5% or more of PACB?
Which tracked 13F managers own PACB?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.